Purpose: Multidisciplinary tumor boards (MDTBs) are universally recommended, but recent literature has challenged their efficiency.
Methods: The American Society of Clinical Oncology (ASCO) conducted a survey of a randomly selected cohort of international ASCO members. The survey was built on SurveyMonkey and was sent via e-mail to a sample of 5,357 members.